{
  "report_rows": [
    {
      "kpi": "Revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$1.123B vs. cons. $1.117B (Visible Alpha, Jul. 22)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted diluted EPS",
      "prediction": "IN-LINE",
      "answer": "pred ~$2.23 vs. cons. $2.213 (Visible Alpha, Jul. 22)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Organic revenue growth",
      "prediction": "BEAT",
      "answer": "pred ~4.0% vs. cons. 3.72% (Visible Alpha, Jul. 22)",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY26 adjusted EPS",
      "prediction": "UNCHANGED",
      "answer": "guide ~$8.70-$8.90 vs. cons. $8.773",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 organic growth",
      "prediction": "UNCHANGED",
      "answer": "guide ~2%-4% vs. cons. 3.98%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 reported revenue growth",
      "prediction": "LOWER",
      "answer": "guide ~6%-8% vs. Street-implied growth just above 8%",
      "confidence": "LOW"
    },
    {
      "kpi": "Q2 margin / H2 recovery commentary",
      "prediction": "UNKNOWN",
      "answer": "margin pressure in Q2; recovery weighted to Q3/Q4; no reliable consensus",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": -2.0,
  "day1_confidence": "LOW",
  "day5_residual_pct": -3.0,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "FOLLOW-THROUGH - unchanged forward estimates and margin uncertainty",
  "day5_confidence": "LOW"
}